1. Home
  2. IBRX vs TFPM Comparison

IBRX vs TFPM Comparison

Compare IBRX & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.54

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Logo Triple Flag Precious Metals Corp.

TFPM

Triple Flag Precious Metals Corp.

HOLD

Current Price

$29.17

Market Cap

6.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
TFPM
Founded
2014
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.8B
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
IBRX
TFPM
Price
$7.54
$29.17
Analyst Decision
Strong Buy
Buy
Analyst Count
7
2
Target Price
$12.57
$40.00
AVG Volume (30 Days)
12.2M
703.3K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
0.72%
EPS Growth
38.71
N/A
EPS
N/A
N/A
Revenue
$113,288,000.00
N/A
Revenue This Year
$88.59
$29.19
Revenue Next Year
$131.15
N/A
P/E Ratio
N/A
$35.57
Revenue Growth
668.31
N/A
52 Week Low
$1.95
$22.60
52 Week High
$12.43
$41.70

Technical Indicators

Market Signals
Indicator
IBRX
TFPM
Relative Strength Index (RSI) 44.85 51.39
Support Level $6.69 $26.89
Resistance Level $8.54 $32.16
Average True Range (ATR) 0.54 0.91
MACD -0.12 0.08
Stochastic Oscillator 12.61 47.58

Price Performance

Historical Comparison
IBRX
TFPM

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

Share on Social Networks: